益佰制药2025年净利预亏2.85亿元至3.42亿元

Group 1 - The core viewpoint of the article is that Yibai Pharmaceutical (600594) is expected to report a net profit loss of between 285 million yuan and 342 million yuan for the year 2025 [1] - The company anticipates a 14% decline in revenue due to reduced sales of its main products [1] - Although the company's cost expenses are expected to decrease by 18%, the total cost expenses will still exceed revenue, leading to the projected loss [1] Group 2 - The financial department of the company plans to recognize an impairment provision for goodwill between 110 million yuan and 132 million yuan based on preliminary impairment testing results [1] - This impairment provision is expected to further increase the company's losses for the period [1]